Pennant Group (PNTG) vs Strata Critical Medical (SRTA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Pennant Group (PNTG) has outperformed Strata Critical Medical (SRTA) over the past year, gaining 29.9% versus a gain of 8.6%. Over five years, PNTG leads with a +69.4% price change compared with -46.8% for SRTA. Pennant Group is the larger company by market cap ($1.22 billion vs $407.3 million), about 3.0 times the size.
Strata Critical Medical converts more of its revenue into profit, with a net margin of 21.0% versus 3.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PNTG | SRTA |
|---|---|---|
| Share price | $34.64 | $4.56 |
| Market cap | $1.22B | $407.30M |
| 1-day change | +1.61% | -5.59% |
| YTD return | +23.06% | -5.20% |
| 1-year return | +29.88% | +8.57% |
| 5-year return | +69.39% | -46.79% |
| P/E ratio (TTM) | 34.30 | — |
| Forward P/E | 22.00 | — |
| EPS (TTM) | $1.01 | $-0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $947.71M | $197.14M |
| Revenue growth (YoY) | +36.31% | +34.28% |
| Net income (latest FY) | $29.58M | $41.35M |
| Gross margin | 18.91% | 20.86% |
| Operating margin | 5.47% | -11.34% |
| Net margin | 3.12% | 20.97% |
| 52-week high | $44.24 | $6.50 |
| 52-week low | $26.40 | $3.95 |
| Distance from 52-week high | -21.70% | -29.85% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +38.57% | +111.18% |
| Average volume | 391.52K | 982.75K |
| Shares outstanding | 35.13M | 89.32M |
| Employees | 9,700 | 327 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Pennant Group is about 3.0 times larger than Strata Critical Medical by market value ($1.22B vs $407.30M).
- PNTG has outperformed SRTA by 21.3 percentage points over the past year.
- Strata Critical Medical is more profitable, keeping 21.0 cents of every revenue dollar as net income versus 3.1 cents for Pennant Group.
About Pennant Group
PNTG stock →The Pennant Group, Inc. provides healthcare services in the United States.
Health Care · Medical/Nursing Services · 9,700 employees
About Strata Critical Medical
SRTA stock →Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States.
Health Care · Medical/Nursing Services · 327 employees
PNTG vs SRTA FAQ
Which is bigger, Pennant Group or Strata Critical Medical?
Pennant Group (PNTG) is larger, with a market capitalization of $1.22B compared with $407.30M for Strata Critical Medical (SRTA).
Which stock has performed better over the past year, PNTG or SRTA?
PNTG returned +29.88% over the past 12 months, compared with +8.57% for SRTA (price return, excluding dividends). Past performance does not predict future results.
Are Pennant Group and Strata Critical Medical in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.